Dermatology Drug Development Summit 2022
Tergus will be exhibiting and presenting at the 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases taking place November 1-3 in Boston, MA.
On Tuesday, November 2nd, Tergus’ Chairman and CSO Dr. Vijendra Nalamothu will host a pre-conference workshop titled “Topical Product Development: An End-to-End Approach of Concept to Commercialization.” Dr. Nalamothu’s colleagues, Alon Mantel, Head of Skin Biology, and Gayathri Krishnan, Associate Director In Vitro Sciences will co-lead the workshop with him where they will discuss optimization of drug delivery platforms and formulation approaches in topical drug development.
On Wednesday, November 3rd, Dr. Nalamothu will also give a presentation at 8:30 am on “Development of a Topical Drug Product in the Post-Pandemic World.”
The 6th Annual Dermatology Drug Development Summit for Inflammatory Skin Diseases is the world’s leading and only forum committed to overcoming significant R&D hurdles and sharing best practices for advancing efficacious next-generation therapies for chronic inflammatory skin conditions.
With the rising demand for patient-specific and alternative treatment options, along with some first-in-class treatments in the likes of Alopecia Areata – the 6th annual meeting addresses genetic discoveries, antibody drug development, delivery strategies, and predictive and diagnostic technologies when developing safe and effective drugs for moderate-to-severe, inflammatory skin conditions.
Schedule a time to stop by and meet with us to discuss your topical development and manufacturing needs by contacting us at [email protected]. For more information about the conference and to register, please click here.